@prefix orcid: <https://orcid.org/> .
@prefix this: <http://purl.org/np/RAfWqAZ-UTw0gNnIXkqQG2l6pPL7o0NgFGMyA2JkH3g7k> .
@prefix sub: <http://purl.org/np/RAfWqAZ-UTw0gNnIXkqQG2l6pPL7o0NgFGMyA2JkH3g7k#> .
@prefix np: <http://www.nanopub.org/nschema#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix ns2: <http://twoc-nlp-database-server-1:8555/solr/triples/select?q=> .
@prefix ns1: <https://uts.nlm.nih.gov/uts/umls/concept/> .
@prefix prov: <http://www.w3.org/ns/prov#> .
@prefix ns3: <http://twoc-nlp-database-server-1:8555/solr/predicates/select?q=> .
@prefix npx: <http://purl.org/nanopub/x/> .

sub:Head {
  this: np:hasAssertion sub:assertion;
    np:hasProvenance sub:provenance;
    np:hasPublicationInfo sub:pubInfo;
    a np:Nanopublication .
}

sub:assertion {
  sub:assertion prov:wasGeneratedBy "S&T TWOC project version 1" .
  
  sub:version prov:value "1"^^xsd:integer .
  
  rdf:object ns1:C0205210 "clinical";
    ns1:C0332281 "associated";
    ns1:C0877248 "adverse events";
    ns1:C1705413 "adverse events";
    ns1:C3272565 "clinical" .
  
  rdf:predicate ns3:TRIPLE_UID:a5s1weub-TRIPLE-ABSTRACT-3 "remain" .
  
  rdf:subject ns1:C0001617 "corticosteroids";
    ns1:C0003232 "antibiotics";
    ns1:C0003237 "antibiotics";
    ns1:C0003404 "antiparasitics";
    ns1:C0005515 "biologics";
    ns1:C0008269 "chloroquine";
    ns1:C0011777 "dexamethasone";
    ns1:C0013227 "drugs";
    ns1:C0020336 "hydroxychloroquine";
    ns1:C0035366 "retroviral";
    ns1:C0052796 "azithromycin";
    ns1:C0087111 "therapeutic";
    ns1:C0181496 "label";
    ns1:C0205195 "combination";
    ns1:C0205423 "certain";
    ns1:C0292818 "ritonavir";
    ns1:C0674432 "lopinavir";
    ns1:C0723712 "therapeutic";
    ns1:C0812732 "azithromycin";
    ns1:C1138226 "favipiravir";
    ns1:C1522485 "label";
    ns1:C1547427 "therapeutic";
    ns1:C1609165 "tocilizumab";
    ns1:C1704787 "certain";
    ns1:C1705425 "label";
    ns1:C1708698 "led";
    ns1:C1947911 "combination";
    ns1:C1947944 "use";
    ns1:C2827499 "label";
    ns1:C3245505 "potential";
    ns1:C3470573 "led";
    ns1:C3539185 "corticosteroids";
    ns1:C3540704 "antibiotics";
    ns1:C3540705 "antibiotics";
    ns1:C3540706 "antibiotics";
    ns1:C3540707 "antibiotics";
    ns1:C3540708 "antibiotics";
    ns1:C3540709 "antibiotics";
    ns1:C3540710 "antibiotics";
    ns1:C3540725 "corticosteroids";
    ns1:C3540726 "corticosteroids";
    ns1:C3540727 "corticosteroids";
    ns1:C3687832 "drugs";
    ns1:C3811910 "combination";
    ns1:C4522130 "label";
    ns1:C4551445 "label";
    ns1:C4553887 "biologics";
    ns1:C4726677 "remdesivir";
    ns1:C5203670 "COVID-19" .
  
  rdfs:Triple-UID ns2:TRIPLE_UID:a5s1weub-TRIPLE-ABSTRACT-3 "a5s1weub-TRIPLE-ABSTRACT-3" .
  
  rdfs:sentence rdfs:label "Although the therapeutic potential of certain repurposed drugs has led to certain repurposed drugs's off-label use against COVID-19, such as anti-retroviral drugs (remdesivir, favipiravir, and lopinavir-ritonavir combination), biologics (tocilizumab), antibiotics (azithromycin), antiparasitics (chloroquine and hydroxychloroquine), and corticosteroids (dexamethasone), unfortunately, the associated clinical neuropsychiatric adverse events remains a critical issue." .
  
  rdfs:triple rdfs:label "Although the therapeutic potential of certain repurposed drugs has led to certain repurposed drugs 's off - label use against COVID-19 , such as anti - retroviral drugs ( remdesivir , favipiravir , and lopinavir - ritonavir combination ) , biologics ( tocilizumab ) , antibiotics ( azithromycin ) , antiparasitics ( chloroquine and hydroxychloroquine ) , and corticosteroids ( dexamethasone ) remains the associated clinical neuropsychiatric adverse events" .
}

sub:provenance {
  sub:assertion prov:generatedAtTime "2021-07-25T21:47:43.303338"^^xsd:dateTime .
}

sub:pubInfo {
  sub:sig npx:hasAlgorithm "RSA";
    npx:hasPublicKey "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCSLeezU8JYlBsrgXOGXX4fxOq4oydsMzMK1CN0Rez2OEd2IYk18R4DetcZXwGhN3Pil7qcgNkiGvTirJXIo8zHl7jVehs19EdYtrttCKEaXRzWIr4LuCrfGedkvonEMWqR8e1GdQsLgEEyM50BD6Qw+srQt9ozcqf/9wG2MAMX9QIDAQAB";
    npx:hasSignature "hvI4eRc7jwmvVn2ah7kNu23dv2ziDI+AJVFcxnfh7gGDaSJwR6AHhe0uE15/oUoZ5q16/VTB4KOFZIBSOksvEAibd+9hvuN+1yRm0G4GASssRZr8z+A9IzSjKuYQnZWoDL8NPeFJ+/rAb/8AuVyqiP1qHeOjAMjPxnbtsx6F2Yo=";
    npx:hasSignatureTarget this: .
  
  this: prov:generatedAtTime "2021-07-25T21:47:43.303338"^^xsd:dateTime;
    prov:wasAttributedTo orcid:0000-0002-8954-0470 .
}